Boolean-network simplification and rule fitting to unravel chemotherapy resistance in non-small cell lung cancer

Boolean networks are powerful frameworks for capturing the logic of gene-regulatory circuits, yet their combinatorial explosion hampers exhaustive analyses. Here, we present a systematic reduction of a published 31-node Boolean model that describes cisplatin- and pemetrexed-resistance in non-small-cell lung cancer to a compact 9-node core that exactly reproduces the original attractor landscape. Through a sequence of biologically guided reductions (31→29→14→9 nodes), the streamlined network shrinks the state space by four orders of magnitude, enabling rapid exploration of critical control points, rules fitting, and candidate therapeutic targets. Extensive synchronous and asynchronous simulations, combined with a Boolean rule-fitting algorithm that removes spurious limit cycles, confirm that the three clinically relevant steady states and their basins of attraction are conserved and reflect resistance frequencies close to those reported in clinical studies. The reduced model provides an accessible scaffold for future mechanistic and drug-discovery studies.

Authors

Institutions

Publication Details

Journal
PLoS ONE
Published
2026-09-15
DOI
https://doi.org/10.1371/journal.pone.0357764
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Boolean-network simplification and rule fitting to unravel chemotherapy resistance in non-small cell lung cancer

Andres Espinoza, Marco Montalva-Medel
PLoS ONE
Computational Drug Discovery Methods
article

Boolean-network simplification and rule fitting to unravel chemotherapy resistance in non-small cell lung cancer

Andres Espinoza, Marco Montalva-Medel
article en

Abstract

Boolean networks are powerful frameworks for capturing the logic of gene-regulatory circuits, yet their combinatorial explosion hampers exhaustive analyses. Here, we present a systematic reduction of a published 31-node Boolean model that describes cisplatin- and pemetrexed-resistance in non-small-cell lung cancer to a compact 9-node core that exactly reproduces the original attractor landscape. Through a sequence of biologically guided reductions (31→29→14→9 nodes), the streamlined network shrinks the state space by four orders of magnitude, enabling rapid exploration of critical control points, rules fitting, and candidate therapeutic targets. Extensive synchronous and asynchronous simulations, combined with a Boolean rule-fitting algorithm that removes spurious limit cycles, confirm that the three clinically relevant steady states and their basins of attraction are conserved and reflect resistance frequencies close to those reported in clinical studies. The reduced model provides an accessible scaffold for future mechanistic and drug-discovery studies.

PLoS ONEVol. 21(9)
Adolfo Ibáñez University (CL), Aix-Marseille Université (FR), Millennium Science Initiative (CL)
Agencia Nacional de Investigación y Desarrollo
Openalex Percentile: Top 96%
Computational Drug Discovery Methods
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Boolean-network simplification and rule fitting to unravel chemotherapy resistance in non-small cell lung cancer — Andres Espinoza, Marco Montalva-Medel · PLoS ONE (2026) | TGRS Research Map | TGRS